Maury Raycroft
Stock Analyst at Jefferies
(1.51)
# 3,479
Out of 5,163 analysts
59
Total ratings
35.56%
Success rate
-6.5%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $36.22 | +18.72% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $77.86 | +4.03% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $21.34 | +195.22% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.39 | +29.53% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $114.22 | +17.32% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $13.95 | +50.54% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.19 | +34.45% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $313.41 | +75.17% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $6.85 | +2.19% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $23.19 | -35.32% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $1.86 | +88.17% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $9.41 | +463.23% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $5.19 | +54.14% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.38 | +693.23% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $13.62 | -55.95% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $17.30 | +9.83% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $3.65 | +310.96% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.28 | +2,014.91% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.46 | +1,475.34% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $2.26 | +8,528.32% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $8.22 | +33.82% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $39.96 | -84.98% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $55.05 | +36.24% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.60 | +323.89% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.69 | +195.86% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $10.61 | +239.30% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $7.31 | +1,336.39% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $48.75 | +252.82% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.12 | +2,116.98% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $12.76 | +229.15% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $36.22
Upside: +18.72%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $77.86
Upside: +4.03%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $21.34
Upside: +195.22%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.39
Upside: +29.53%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $114.22
Upside: +17.32%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $13.95
Upside: +50.54%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.19
Upside: +34.45%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $313.41
Upside: +75.17%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $6.85
Upside: +2.19%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $23.19
Upside: -35.32%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $1.86
Upside: +88.17%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $9.41
Upside: +463.23%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.19
Upside: +54.14%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.38
Upside: +693.23%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $13.62
Upside: -55.95%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $17.30
Upside: +9.83%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $3.65
Upside: +310.96%
Mar 13, 2024
Initiates: Buy
Price Target: $6
Current: $0.28
Upside: +2,014.91%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.46
Upside: +1,475.34%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $2.26
Upside: +8,528.32%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $8.22
Upside: +33.82%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $39.96
Upside: -84.98%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $55.05
Upside: +36.24%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $2.60
Upside: +323.89%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.69
Upside: +195.86%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $10.61
Upside: +239.30%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $7.31
Upside: +1,336.39%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $48.75
Upside: +252.82%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.12
Upside: +2,116.98%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $12.76
Upside: +229.15%